The clinical implications of COVID-19 have changed since SARS-CoV-2 first emerged in
humans. The current high levels of population immunity, due to prior infection and/or …

Long Covid is defined by a wide range of symptoms that persist after the acute phase of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Commonly …

Purpose People living with cancer and haematological malignancies are at an increased
risk of hospitalisation and death following infection with acute respiratory syndrome …

Background: Cancer patients show increased morbidity with COVID-19 and need effective
immunization strategies. Many healthcare regulatory agencies recommend administering …

Patients with cancer are at increased risk of hospitalisation and mortality following severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, the SARS-CoV …

Background COVID-19 sequelae can affect about 15% of patients with cancer who survive
the acute phase of SARS-CoV-2 infection and can substantially impair their survival and …

Importance Accurate identification of patient groups with the lowest level of protection
following COVID-19 vaccination is important to better target resources and interventions for …

PURPOSE Although representing the majority of newly diagnosed cancers, patients with
breast cancer appear less vulnerable to COVID-19 mortality compared with other …

Hematopoietic cell transplantation (HCT) and chimeric antigen receptor T cell therapy (CAR-
T) recipients who develop Coronavirus disease 2019 (COVID-19) can have decreased …

Background The first case of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) infection in Rio Grande do Norte, northeastern Brazil, was diagnosed on March 12 …